Skip to main content
TipRanks
Go Ultimate75% OFF

Christopher David Ozeroff Insider Profile

4 Followers

Christopher David Ozeroff, S.V.P., General Counsel at Oruka Therapeutics, holds 50.97K shares in Oruka Therapeutics (Ticker: ORKA). Most recently, Christopher David Ozeroff Bought 50,000 shares of Oruka Therapeutics on Nov 23, 2021 for an estimated value of $113.00K.

Christopher David Ozeroff's Trading History

ORKA
Oruka Therapeutics
Nov 23, 2021S.V.P., General CounselInformative Buy113.00K$5.06M
ORKA
Insider Shares: 50.97K (0.35%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Nov 23, 2021Informative Buy$113.00K50,000$2.26―
Apr 05, 2017Uninformative Sell$1.01K418$2.41―
Mar 01, 2017Uninformative Sell$1.21K465$2.61―
Sep 21, 2016Uninformative Sell$3.42K1,185$2.89―
Apr 06, 2016Uninformative Sell$1.29K366$3.52―

You May Also Like

Christopher David Ozeroff insider profile FAQ

What stocks does Christopher David Ozeroff hold?
Christopher David Ozeroff holds: ORKA stocks.
What was Christopher David Ozeroff’s latest transaction?
Christopher David Ozeroff’s latest transaction was an Informative Buy of $113.00K.
What is Christopher David Ozeroff's role in Oruka Therapeutics?
Christopher David Ozeroff's role in Oruka Therapeutics is S.V.P., General Counsel.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.